During the past decade, Adler Aphasia Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Adler Aphasia Center" #1 collaborator was "Adler Aphasia Center" with 1 trials as a collaborator, "Pitkin Foundation" with 1 trials as a collaborator and "Temple University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Adler Aphasia Center" are "Stroke" (2 trials), "Aphasia" (1 trials), "Aphasia, Acquired" (1 trials) and "Spatial Neglect" (1 trials). Many other conditions were trialed in "Adler Aphasia Center" in a lesser frequency.

Most popular intervention types in "Adler Aphasia Center" are "Behavioral" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anodal tDCS" (1 trials), "Aphasia therapy" (1 trials), "Conversation Treatment for Aphasia" (1 trials), "Sham tDCS" (1 trials) and "prism adaptation treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Adler Aphasia Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Adler Aphasia Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Adler Aphasia Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Adler Aphasia Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".